Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1987-08-27
1990-07-31
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Lymphokine
424 92, A61K 3909, A61K 3912
Patent
active
049449427
ABSTRACT:
Horses can be immunized by the intranasal administration of antigenic material which provokes the proliferation of antibodies which reduce or neutralize the virulence of invasive microorganisms. These antigenic materials may be inactivated whole organisms, extracts from such organisms, or recombinant DNA or synthetic peptide antigens. This antigenic material can be combined with adjuvants and transdermal carriers or it can just be carried in sterile water. The intranasal vaccination may be part of a total regimen that includes other routes of administration such as intramuscular injection.
REFERENCES:
patent: 3852420 (1974-12-01), Usdin
patent: 4500513 (1985-02-01), Brown et al.
patent: 4582798 (1986-04-01), Brown et al.
Polly et al., Journal of Infectious Diseases, vol. 131, No. 3, pp. 217-224, Human Strept Vaccine Aerosol Spray, Protective Studies with a Group A Streptococcal M. Protein Vaccine, Mar. 1975.
D'Alessandri, Journal of Infectious Diseases, vol. 138, No. 6, Dec. 1978, pp. 712-718, Protective Studies with Group A Streptococcal M. Protein Vaccine, Human Nasal Strept Vaccine.
Galan et al, Infection & Immunity, vol. 47, No. 3, pp. 623-628, Mar. 1985, S. equi in Horses Locally, Mucosal Nasopharyngeal Immune Responses of Horses to Protein Antigens.
I. Van de Rijn, pp. 444-448, vol. 27 (Feb. 1980) of Infection and Immunity.
American Journal of Veterinary Research, 41(2): Feb. 1980, by J. M. Cummins and B. Rosenquist, Protection of Calves Against Rhinovirus Infection by Nasal Secretion Interferon Induced by Infectious Bovine Rhinotracheitis Virus, pp. 161-165.
Commonwealth Agricultural Bureau, 1986, NR. 86162129; J. F. Timoney et al.: "The Protective Response of the Horse to an Avirulent Strain of Stroptococcus equi", & Coll. Vet. Med., Cornell Univ., Ithaca, NY 14853.
Chemical Abstracts, Band 72, 1970 Seite 179 Zusammenfassung NR. 98582a, Columbus, Ohio, U.S.; B. T. Rouse et al; "Response of Ponies to Myxovirus Influenza A-equi 2. I. Serum and Nasal Antibody Titers Following Exposure", & Can. J. Comp. Med., 1970, 34(1), 1-6.
Brown Karen K.
Bryant Sharon A.
Gil Joseph C.
Griffin Ronald W.
Mobay Corporation
Whalen Lyndanne M.
LandOfFree
Intranasal vaccination of horses with inactivated microorganisms does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intranasal vaccination of horses with inactivated microorganisms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intranasal vaccination of horses with inactivated microorganisms will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1397985